List of Bortezomib drug patents

Bortezomib is owned by Fresenius Kabi Usa.

Bortezomib contains Bortezomib.

Bortezomib has a total of 1 drug patent out of which 0 drug patents have expired.

Bortezomib was authorised for market use on 06 November, 2017.

Bortezomib is available in powder;intravenous dosage forms.

The generics of Bortezomib are possible to be released after 03 November, 2032.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8962572 FRESENIUS KABI USA Bortezomib formulations
Nov, 2032

(9 years from now)

Drugs and Companies using BORTEZOMIB ingredient

Market Authorisation Date: 06 November, 2017

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

BORTEZOMIB family patents

3

United States

1

Canada

1

Australia

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic